HNGE - NYSE
Hinge Health, Inc.
$58.66
+6.6%Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
At a Glance
Live SnapshotHinge Health, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Hinge Health, Inc. Income Statement
HNGE • NYSE
| Hinge Health, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
REVENUE | |||
587.9M | 390.4M | 292.7M | |
GROSS PROFIT | |||
(119.6M) | (89.8M) | (98.6M) | |
468.2M | 300.6M | 194.2M | |
OPERATING INCOME | |||
(1B) | (325M) | (324.7M) | |
(646.5M) | (227.5M) | (214.6M) | |
(368.1M) | (97.5M) | (110.1M) | |
-546.4M | -24.4M | -130.5M | |
PRE-TAX INCOME | |||
19.1M | 13.2M | 22M | |
-527.3M | -11.3M | -108.5M | |
NET INCOME | |||
(998K) | (677K) | -405K | |
-528.3M | -11.9M | -108.1M |
SEC Filings
HNGE - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 17, 2026 | June 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 17, 2026 | March 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 03, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 10, 2026 | February 10, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 12, 2025 | November 10, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 07, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 04, 2025 | November 04, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 13, 2025 | August 06, 2025 | 2025 |
Related Guides
Continue your HNGE research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.